Amgen (AMGN) PT Lowered to $350 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $412.84 -1.13%
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 17 | New: 36
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 17 | New: 36
Join SI Premium – FREE
Jefferies analyst Michael Yee lowered the price target on Amgen (NASDAQ: AMGN) to $350.00 (from $380.00) while maintaining a Buy rating.
You May Also Be Interested In
- Fastenal (FAST) PT Raised to $51 at DA Davidson
- Amgen (AMGN) PT Raised to $440 at Cantor Fitzgerald - 'Now a Clear Consensus Long'
- Anheuser-Busch InBev (ABI:BB) (BUD) PT Lowered to EUR76 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
